News
Press Releases and Publications
Duo Oncology Announces Close of Initial Seed Investment
​
Duo Oncology is pleased to announce a $1M+ seed investment led by UPMC oncologists Dr. Stanley Marks and Dr. Jing-Zhou Hou.
Duo Oncology Joins LifeX Incubator
​
LifeX Labs welcomes new portfolio company, Duo Onoclogy, into incubator program.
Duo Oncology Appoints Dr. Stanley Marks to Board of Directors
​
Duo Oncology is pleased to welcome Dr. Stanley Marks to its board of directors. Dr. Marks is a world renown oncology and chairman of the UPMC Hillman Cancer Center.
More
Duo Oncology Options Nanoparticle Platform from University of Pittsburgh
​
Duo Oncology signed an option to exclusively license nanoparticle prodrug chemistry patented developed in the laboratory of Dr. Song Li and patented by the University of Pittsburgh
More